Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason R Pitarresi

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Oncotarget|November 18, 2015
Single agent BMS-911543 Jak2 inhibitor has distinct inhibitory effects on STAT5 signaling in genetically engineered mice with pancreatic cancerThomas A Mace, Reena Shakya, Omar Elnaggar, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 18, 2024
PRRX1 Has Functional Roles in Pancreatic Acinar to Ductal Metaplasia and CarcinogenesisNoriyuki Nishiwaki, Kensuke Sugiura, Kensuke Suzuki, et al.
Biorxiv : the Preprint Server for Biology|August 16, 2024
Mitochondrial Ca<sup>2+</sup> controls pancreatic cancer growth and metastasis by regulating epithelial cell plasticityJillian S Weissenrieder, Jessica Peura, Usha Paudel, et al.
Cancer Research|September 3, 2025
MYC and p53 Alterations Cooperate through VEGF Signaling to Repress Cytotoxic T Cell and Immunotherapy Responses in Prostate CancerKatherine C Murphy, Kelly D DeMarco, Lin Zhou, et al.
Cell Reports|April 26, 2025
Mitochondrial Ca<sup>2+</sup> controls pancreatic cancer growth and metastasis by regulating epithelial cell plasticityJillian S Weissenrieder, Jessica Peura, Usha Paudel, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
Nanoparticle delivery of innate immune agonists combines with senescence-inducing agents to mediate T cell control of pancreatic cancerLoretah Chibaya, Christina F Lusi, Kelly D DeMarco, et al.
Gut|November 1, 2016
IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancerThomas A Mace, Reena Shakya, Jason R Pitarresi, et al.
The Journal of Clinical Investigation|May 9, 2017
Long-lived keratin 15+ esophageal progenitor cells contribute to homeostasis and regenerationVéronique Giroux, Ashley A Lento, Mirazul Islam, et al.
Molecular Cancer Research : MCR|November 15, 2022
Tumor-Suppressive and Immune-Stimulating Roles of Cholesterol 25-hydroxylase in Pancreatic Cancer CellsNoreen McBrearty, Christina Cho, Jinyun Chen, et al.
Cancer Discovery|October 24, 2025
P21-positive senescent stromal cells promote prostate cancer immune suppression and progression that can be reversed by senolytic therapyLin Zhou, Kelly D DeMarco, Katherine C Murphy, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Oncotarget|November 18, 2015
Single agent BMS-911543 Jak2 inhibitor has distinct inhibitory effects on STAT5 signaling in genetically engineered mice with pancreatic cancerThomas A Mace, Reena Shakya, Omar Elnaggar, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 18, 2024
PRRX1 Has Functional Roles in Pancreatic Acinar to Ductal Metaplasia and CarcinogenesisNoriyuki Nishiwaki, Kensuke Sugiura, Kensuke Suzuki, et al.
Biorxiv : the Preprint Server for Biology|August 16, 2024
Mitochondrial Ca<sup>2+</sup> controls pancreatic cancer growth and metastasis by regulating epithelial cell plasticityJillian S Weissenrieder, Jessica Peura, Usha Paudel, et al.
Cancer Research|September 3, 2025
MYC and p53 Alterations Cooperate through VEGF Signaling to Repress Cytotoxic T Cell and Immunotherapy Responses in Prostate CancerKatherine C Murphy, Kelly D DeMarco, Lin Zhou, et al.
Cell Reports|April 26, 2025
Mitochondrial Ca<sup>2+</sup> controls pancreatic cancer growth and metastasis by regulating epithelial cell plasticityJillian S Weissenrieder, Jessica Peura, Usha Paudel, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
Nanoparticle delivery of innate immune agonists combines with senescence-inducing agents to mediate T cell control of pancreatic cancerLoretah Chibaya, Christina F Lusi, Kelly D DeMarco, et al.
Gut|November 1, 2016
IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancerThomas A Mace, Reena Shakya, Jason R Pitarresi, et al.
The Journal of Clinical Investigation|May 9, 2017
Long-lived keratin 15+ esophageal progenitor cells contribute to homeostasis and regenerationVéronique Giroux, Ashley A Lento, Mirazul Islam, et al.
Molecular Cancer Research : MCR|November 15, 2022
Tumor-Suppressive and Immune-Stimulating Roles of Cholesterol 25-hydroxylase in Pancreatic Cancer CellsNoreen McBrearty, Christina Cho, Jinyun Chen, et al.
Cancer Discovery|October 24, 2025
P21-positive senescent stromal cells promote prostate cancer immune suppression and progression that can be reversed by senolytic therapyLin Zhou, Kelly D DeMarco, Katherine C Murphy, et al.
Pageof 6